Piramal Pharma Ltd. (PPLPHARMA): Piramal Pharma Share Price Hits Fresh 52-Week High at Rs 215.60
- August 10, 2026
- Posted by: Harsh Piplani
- Category: News
Piramal Pharma rose to Rs 214.60, up 2.48% today, after touching a fresh 52-week high of Rs 215.60. Market capitalisation stood at Rs 27,878.43 crore.
Piramal Pharma Share Price traded at Rs 214.60 on 10 August 2026 at 10:16 AM IST, up Rs 5.20 or 2.48% from the previous close of Rs 209.40, after touching a fresh 52-week high of Rs 215.60. With a market capitalisation of Rs 27,878.43 crore, the stock has moved into focus in today’s Stock Market Today and Share Market Today watchlists as investors track 52 Week High Stocks and Market Movers.
The verified data confirms the price event, but it does not establish a company-specific catalyst behind the move. Even so, the combination of a one-year high, intraday strength from the open, and turnover of Rs 2.99 crore has made Piramal Pharma Stock News relevant for traders looking at price action and for long-term market participants comparing valuation and profitability metrics.
Why is the stock trending? The immediate answer is straightforward: Piramal Pharma Share Price Today opened at Rs 209.80, did not slip below that level during the session low, and climbed to Rs 215.60, its yearly high. Important financial metrics also shape the discussion. The stock is trading at a P/E ratio of 31.12 and a P/B ratio of 0.45, while reported ROE stands at -2.89 and ROCE at -0.26. Investors tracking Univest may now monitor whether the stock sustains above the fresh 52-week peak, how its valuation compares with the Healthcare sector benchmark, and how its profitability profile stacks up against listed peers.
Piramal Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 214.6 |
| Previous Close | Rs 209.4 |
| Today's Change | +Rs 5.2 (+2.48%) |
| Day Open | Rs 209.8 |
| Fresh 52-Week High | Rs 215.6 |
| Day Low | Rs 209.8 |
| Current Volume | 1,39,184 |
| Turnover | Rs 2.99 crore |
| Market Capitalisation | Rs 27,878.43 crore |
Piramal Pharma Ltd. (PPLPHARMA) traded at Rs 214.6. versus the previous close of Rs 209.4, a rise of 2.48%. The stock opened at Rs 209.8, reached Rs 215.6, touched Rs 209.8. Reported volume was 1,39,184.
Piramal Pharma Share Price Today shows a clear intraday breakout profile, with the stock opening at Rs 209.80, rising to a fresh 52-week high of Rs 215.60, and trading at Rs 214.60 at the time of the update. That keeps the stock firmly above the previous close of Rs 209.40 and highlights a positive session move of 2.48%.
From a pure price action perspective, the session started close to the previous close and then strengthened through the morning. The day’s low was Rs 209.80, exactly matching the opening price, which indicates that early trade did not see a dip below the opening print. The day’s high of Rs 215.60 set the new 52-week peak, while the current price of Rs 214.60 suggests the stock held on to most of its intraday gains after touching that level.
Turnover stood at Rs 2.99 crore and current volume was 1,39,184 shares at the time of the update. That makes this Piramal Pharma Share Price Update notable not only because of the one-year high but also because the move came with measurable trading participation. For readers following Piramal Pharma Share Price Live, the key takeaway is that the stock has moved from Rs 209.40 on the previous close to a new yearly high zone above Rs 215 in the current session. With that price event established, the next step is to examine whether the fundamentals add support to investor attention.
Piramal Pharma Ltd. (PPLPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 27,878.43 crore |
| P/E Ratio | 31.12x |
| P/B Ratio | 0.45x |
| ROE | -2.89% |
| ROCE | -0.26% |
Piramal Pharma Ltd. was valued at a P/E ratio of 31.12x, a P/B ratio of 0.45x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 31.12x |
| Benchmark Median P/E | 21.04x |
| Benchmark Average P/E | 71.82x |
| Benchmark P/E Range | 0x to 3,417.8x |
| Company P/B Ratio | 0.45x |
| Benchmark Median P/B | 1.89x |
| Company ROE | -2.89% |
| Benchmark Median ROE | 10.7% |
| Company ROCE | -0.26% |
| Benchmark Median ROCE | 13.16% |
| Company Market Capitalisation | Rs 27,878.43 crore |
| Benchmark Median Market Cap | Rs 130.8 crore |
Piramal Pharma Ltd. (PPLPHARMA) is classified under sector: Healthcare.
Piramal Pharma Ltd. (PPLPHARMA) has a P/E ratio of 31.12x, which is above the benchmark median of 21.04x, a difference of +47.91%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Piramal Pharma Ltd. (PPLPHARMA) has a ROE of -2.89%, which is below the benchmark median of 10.7%, a difference of -127.01%. Piramal Pharma Ltd. (PPLPHARMA) has a ROCE of -0.26%, which is below the benchmark median of 13.16%, a difference of -101.98%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 3,032.97 | 31.12 | 0.45 | -2.89 | -0.26 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,707.2 | 40.2 | 8.18 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,631.45 | 63.43 | 6.27 | 18.65 | 22.17 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,537.93 | 33.3 | 6.87 | -2.6 | 16.92 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,513.58 | 176.28 | 3.26 | 13.9 | 12.97 |
Piramal Pharma Ltd. (PPLPHARMA) has a P/E ratio of 31.12x compared with the displayed peer median of 40.2x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Piramal Pharma Ltd. (PPLPHARMA) has a market capitalisation of Rs 27,878.43 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Piramal Pharma
This stock is attracting attention because a verified price event is now supported by visible valuation and sector contrasts. For market participants following Breakout Stocks, Momentum Stocks and 52 Week High Stocks, Piramal Pharma is on the radar for the following data-backed reasons.
- Fresh price milestone: Piramal Pharma Share Price touched a new 52-week high of Rs 215.60 and was trading at Rs 214.60, up 2.48% from Rs 209.40.
- Intraday strength: The stock opened at Rs 209.80, the same as the day’s low, suggesting the session strengthened after the open.
- Trading activity: Volume stood at 1,39,184 shares with turnover of Rs 2.99 crore, keeping the move visible in daily Stock Updates.
- Large-company context: Market capitalisation of Rs 27,878.43 crore is far above the same-sector median of Rs 130.80 crore and average of Rs 460.68 crore.
- Mixed fundamentals: P/E at 31.12 is above the sector median of 21.04, while P/B at 0.45 is below the sector median of 1.89; ROE and ROCE remain below sector norms.
- Peer contrast: The company is much larger than the supplied peers, but peer profitability metrics are generally stronger.
About Piramal Pharma
Piramal Pharma Ltd. (PPLPHARMA) is a listed company in the Healthcare sector. In the supplied data, the company is identified under the NSE-style symbol PPLPHARMA and is being analysed here through verified market data associated with a fresh 52-week high event. The current market focus is therefore on Piramal Pharma Share News, market capitalisation, sector positioning and peer comparison rather than on any unverified narrative around operations or catalysts.
Within the comparison data provided, Piramal Pharma is assessed alongside healthcare and pharmaceutical businesses such as Dishman Carbogen Amcis, Kwality Pharmaceuticals, Beta Drugs and Sai Parenteral’s, as well as Dr Agarwals Eye Hospital from healthcare services. That comparison indicates that the market views Piramal Pharma as part of the broader Healthcare investment universe, where scale, valuation and profitability are being weighed simultaneously. For investors scanning Piramal Pharma Latest News and Piramal Pharma Company News, the clearest verified takeaway today is that the stock has reached a one-year high while still presenting a mixed fundamental profile against sector and peer benchmarks. Univest will typically be relevant for tracking how such event-led moves evolve across price, valuation and sector context.
Track Piramal Pharma Share Price on Univest
Use Piramal Pharma Ltd. (PPLPHARMA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers tracking Piramal Pharma Share Price can use Univest to follow live share price movements, 52-week levels, market-cap changes, valuation ratios such as P/E and P/B, and comparative metrics across peers and the Healthcare sector. For event-led moves like today’s fresh yearly high, that combination helps separate a simple price spike from a broader market re-rating discussion.
Univest also helps users monitor Piramal Pharma Share Price Today alongside stock performance, peer comparison, sector analysis and key ratio-based context in one place. For investors who follow Piramal Pharma Stock News, Piramal Pharma Share Price Live screens and daily market updates, the most relevant next step is to watch whether the stock sustains around the new 52-week peak while its valuation and profitability metrics continue to be assessed against the wider healthcare benchmark.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the latest Piramal Pharma Share Price Today?
Ans. Piramal Pharma Share Price Today was Rs 214.60 at 10:16 AM IST on 10 August 2026. The stock was up Rs 5.20, or 2.48%, from the previous close of Rs 209.40.
Did Piramal Pharma hit a fresh 52-week high today?
Ans. Yes, Piramal Pharma touched a fresh 52-week high of Rs 215.60 during the session. It was trading slightly below that level at Rs 214.60 when the verified market update was captured.
Why is Piramal Pharma Share Price rising today?
Ans. The verified data confirms that Piramal Pharma Share Price rose 2.48% and reached a one-year high. However, the supplied market data establishes the price event itself and does not identify a company-specific catalyst.
What were the day high, day low and opening price for Piramal Pharma?
Ans. Piramal Pharma opened at Rs 209.80, which was also the day’s low in the captured update. The stock then climbed to a day high of Rs 215.60, marking the fresh 52-week peak.
What is the market capitalisation of Piramal Pharma?
Ans. Piramal Pharma’s market capitalisation stood at Rs 27,878.43 crore in the supplied data. That is substantially above the same-sector benchmark median of Rs 130.80 crore and average of Rs 460.68 crore.
How is Piramal Pharma valued on P/E and P/B ratios?
Ans. Piramal Pharma is trading at a P/E ratio of 31.12 and a P/B ratio of 0.45. Its P/E is above the sector median of 21.04, while its P/B is below the sector median of 1.89.
How do Piramal Pharma’s ROE and ROCE compare with the sector?
Ans. Piramal Pharma reported ROE of -2.89 and ROCE of -0.26. Both are below the Healthcare sector median values of 10.7 for ROE and 13.16 for ROCE in the supplied benchmark.
How active was trading in Piramal Pharma today?
Ans. Trading volume in Piramal Pharma stood at 1,39,184 shares, with turnover of Rs 2.99 crore at the time of the update. That activity accompanied the stock’s move to a fresh yearly high.
How does Piramal Pharma compare with its listed peers?
Ans. Piramal Pharma’s market cap of Rs 27,878.43 crore is far above supplied peers such as Dishman Carbogen Amcis, Kwality Pharmaceuticals and Beta Drugs. However, several peers show stronger ROE and ROCE than Piramal Pharma.
Where can investors track Piramal Pharma Share Price live?
Ans. Investors can track Piramal Pharma Share Price live on Univest, including price moves, 52-week levels, market cap, valuation ratios, peer comparison and broader Healthcare sector benchmarks linked to the stock.
